In reply to: Limitations in using the EFLM WG-A/ISO approach for assessment of reagent lot variability.

Thelen, Marc H M; van Schrojenstein Lantman, Marith; Boursier, Guilaine; Vanstapel, Florent; Panteghini, Mauro

Thelen, Marc H M; van Schrojenstein Lantman, Marith; Boursier, Guilaine; Vanstapel, Florent; Panteghini, Mauro.

Afiliação

Thelen MHM; Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, the Netherlands.
van Schrojenstein Lantman M; Foundation for Quality Assurance in Laboratory Medicine (SKML), Nijmegen, the Netherlands.
Boursier G; Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, the Netherlands.
Vanstapel F; Department of Genetics, Rare Diseases and Personalized, Medicine Rare Diseases and Autoinflammatory Unit, CHU Montpellier, University of Montpellier, Montpellier, France.
Panteghini M; Laboratory Medicine, University Hospital Leuven, Leuven, Belgium.

Clin Chem Lab Med ; 61(11): e218-e220, 2023 10 26.

Article em En | MEDLINE | ID: mdl-37261942

Assuntos

Indicadores e Reagentes; Kit de Reagentes para Diagnóstico; Controle de Qualidade; Indicadores e Reagentes/normas

Palavras-chave

CLSI-ep26; analytical performance specifications; lot-to-lot variation; measurement uncertainty; method evaluation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Kit de Reagentes para Diagnóstico / Indicadores e Reagentes Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google